Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
A very fast-paced company that has a lot of turning around to do under new leadership. I am eager and excited to see what the new CEO does and hope to see Karyopharm go from being a fledgling company to a well-established, competitive company.
¿Qué son algunas de las mejores cosas de tu equipo?
I get to work cross-functionally with a variety of talented, funny, hardworking people.
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
There are certain teams that are trying really hard to improve on the company culture and they are bright spots in my day. Work wouldn't be the same without them.
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
There are certain members of the leadership team that are incredibly forward-thinking and are trying to improve on Karyopharm culture as a whole. I think they're doing a fabulous job and hope they keep at it!
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
I have an incredible manager and consider myself very lucky to be able to learn from them at such a crucial stage in my career. I'm consistently impressed with their thoughtfulness, consideration, and well-rounded approach to management.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×